Patents by Inventor Ritha Gidlöf

Ritha Gidlöf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic lactones for treatment of cancer
    Patent number: 9150531
    Abstract: The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/NF-?B signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising such novel compounds, its use and a method thereof, is also disclosed.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: October 6, 2015
    Assignee: Glactone Pharma Development AB
    Inventors: Ritha Gidlöf, Martin Johansson, Olov Sterner, Eduardo Muñoz
  • TRICYCLIC LACTONES FOR TREATMENT OF CANCER
    Publication number: 20130310451
    Abstract: The present invention discloses novel compounds useful for the inhibition of IL-6/STAT signaling and/or PI3K/NF-?B signaling in the treatment of associated diseases or conditions, e.g. cancer. A pharmaceutical composition comprising such novel compounds, its use and a method thereof, is also disclosed.
    Type: Application
    Filed: July 18, 2011
    Publication date: November 21, 2013
    Applicant: GLACTONE PHARMA DEVELOPMENT AB
    Inventors: Ritha Gidlöf, Martin Johansson, Olov Sterner, Eduardo Muñoz